WuXi BioLogics sets stage for $500m HK float

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

WuXi BioLogics sets stage for $500m HK float

John Loh
May 16, 2017 05:30 am
Cosmo_drugs_PA_230x150
Pharmaceuticals being produced at the company STADA Azneimittel AG in Bad Vilbel, Germany, 20 June 2016. STADA specialised on the production of generic medicaments and over-the-counter pharmaceuticals for pharmacies. PHOTO: FRANK RUMPENHORST/dpa | Frank Rumpenhorst/DPA/PA Images

WuXi BioLogics will kick off pre-deal investor education for its Hong Kong IPO on Wednesday as it looks to raise $400m-$500m.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsChina Merchants Securities CoEquityBank of AmericaHong Kong SARAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificEmerging Markets
JL
John Loh
Gift this article